Rae R. Matsumoto
Department of Pharmaceutical Sciences
College of Pharmacy
University of Oklahoma Health Sciences Center
P.O. Box 26901
USA
Name/email consistency: high
- Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies. Matsumoto, R.R., Potelleret, F.H., Mack, A., Pouw, B., Zhang, Y., Bowen, W.D. Pharmacol. Biochem. Behav. (2004)
- Sigma receptors: potential medications development target for anti-cocaine agents. Matsumoto, R.R., Liu, Y., Lerner, M., Howard, E.W., Brackett, D.J. Eur. J. Pharmacol. (2003)
- Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Matsumoto, R.R., McCracken, K.A., Pouw, B., Zhang, Y., Bowen, W.D. Neuropharmacology (2002)
- N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice. Matsumoto, R.R., McCracken, K.A., Pouw, B., Miller, J., Bowen, W.D., Williams, W., De Costa, B.R. Eur. J. Pharmacol. (2001)
- (+/-)-SM 21 attenuates the convulsive and locomotor stimulatory effects of cocaine in mice. Matsumoto, R.R., Mack, A.L. Eur. J. Pharmacol. (2001)
- Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice. Matsumoto, R.R., McCracken, K.A., Friedman, M.J., Pouw, B., De Costa, B.R., Bowen, W.D. Eur. J. Pharmacol. (2001)
- Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters. Matsumoto, R.R., Hewett, K.L., Pouw, B., Bowen, W.D., Husbands, S.M., Cao, J.J., Hauck Newman, A. Neuropharmacology (2001)
